Nocardiosis
Nocardia · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Nocardia is a filamentous aerobic actinomycete causing pulmonary, cutaneous and disseminated (especially cerebral) infection, mainly in cell-mediated immunosuppression. CNS dissemination is common, so brain imaging is routine.
Red flags
- Focal neurological deficit (cerebral abscess)
- Disseminated disease with multi-organ involvement
- Respiratory failure
- Severe immunosuppression
- Treatment failure with resistant species
Assessment
Differential diagnosis
- Tuberculosis
- Invasive fungal infection (aspergillosis)
- Lung malignancy
- Actinomycosis
- Bacterial lung abscess / brain abscess
Investigations
- Sputum/tissue microscopy and culture (modified acid-fast, prolonged incubation)
- CT chest (nodules, cavitation, consolidation)
- MRI/CT brain to exclude cerebral abscess (routine in disseminated/pulmonary disease)
- Species identification and susceptibility testing
- HIV test and immune status assessment
- Blood cultures in disseminated disease
Management
- Suspect in immunosuppressed patients with pulmonary and/or CNS lesions
- Alert lab for modified acid-fast staining and prolonged culture
- Obtain tissue/respiratory samples and species-level identification with susceptibilities
- Image the brain in all significant/disseminated cases
- Start empiric high-dose co-trimoxazole, often with a second agent in severe disease
- Drain brain or other abscesses where surgically appropriate
- Adjust therapy to species susceptibility (resistance varies widely)
- Reduce immunosuppression where feasible
- Give prolonged therapy (months) with longer courses for CNS/disseminated disease
- Monitor marrow and renal function on co-trimoxazole
- Watch for and treat relapse
- Arrange long-term follow-up imaging
Drugs & doses
Co-trimoxazole (trimethoprim/sulfamethoxazole) 15 mg/kg/day of trimethoprim IV/PO in divided doses
Add amikacin 7.5 mg/kg IV every 12 h for severe/disseminated disease
Imipenem 500 mg IV every 6 h (combination in CNS/severe disease)
Linezolid 600 mg IV/PO twice daily (active against most species, option in sulfa allergy)
Disposition
Admit for workup and IV therapy; ID management; neurosurgery for brain abscess; long-term follow-up.
Complications & pitfalls
- Cerebral abscess and neurological sequelae
- Dissemination to skin, bone and other organs
- Relapse with inadequate duration
- Co-trimoxazole marrow/renal toxicity
- Mortality in disseminated disease
Exam pearls
- Always image the brain - cerebral nocardiosis is frequent and may be silent
- Co-trimoxazole is the cornerstone; combine agents in severe disease pending susceptibilities
- Species vary markedly in resistance; identification matters
- Linezolid is uniformly active and oral, useful in sulfa allergy
- Prolonged courses (6-12 months) reduce relapse, especially with CNS disease
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.